Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CLBS aren't those $1.50-$1.60 buys sitting pretty now? Patience.
Might actually have a green day today! $CLBS
Dollar here we come. What a diamond in the rough here.
Geez I’m really getting tired of the nonsense. Everytime I buy more we take another beating. How low will we go.
Already up in postmarket.
$CLBS nice inside day..will blowup soon.
Agree the same happened with GRN* last week.
$CLBS mm's probable flushing before incoming Covid-Lung pr then they blow it sky high with a huge gap up so panic sellers become panic buyers seen it a million times..even putting aside CLBS119 for a moment the rest of their pipeline is probably worth north of $7.50/share so these past two trading sessions are quite the joke.
https://clinicaltrials.gov/ct2/show/NCT04522817?cond=COVID&sfpd_s=08%2F21%2F2020&sfpd_e=09%2F04%2F2020&sort=nwst&draw=2&rank=8
Great time to buy below 2.00 Overshot 2.15 gap.
$CLBS quietly add low don't look at it for another 1-2 months and you'll likely be pleasantly surprised is all I can tell you because it makes absolutely zero sense trading at cash with a bunch of offerings completed over $2 and a great pipeline..the whole health care sector is being obliterated right now so it's not just Caladrius I'm buying the fear because I did the DD and believe jmho!
Throwing the baby with the bath water out here. Big disappointment.
S3 filled. Great. Where our news?
Nice News:
Overall, net income was $6.6 million for the three months ended June 30, 2020, which included a $10.9 million income tax benefit from the sale of New Jersey net operating losses, compared to net loss of $5.1 million for the three months ended June 30, 2019.
Insider acquired 51063 shares @ $2.35 on 7/28/20
Common Stock 7/28/2020 A 51063 (1) A $2.35
Waiting patently. Fingers are crossed over and over. Gltu as well.
$CLBS just hang in there the 8/13 data is all that counts CFO leaving means nada he's been there 9 years.
Is the CFO dumping his shares? Any thoughts? Thanks
These aren’t good developments. Stuck taking a beating. Time will tell.
Any idea when that is going to occur. Thanks
Holding and adding when I can. Waiting for this news.
$CLBS company Covid-Lung (CLBS119) update coming in the Q2 e/r CC and they probably brought the news board member aboard (check his credentials) to close the huge Japan deal (CLBS12)..the stock incredibly still trades near cash on hand with explosive catalysts and a strong pipeline..just hold for future 10 bagger.
https://www.caladrius.com/
Let’s hope we get something good. Loaded and waiting. Gltu
$CLBS see what happens next week with their pipeline updates..e/r is August 6
Covid-lung enrollment # and it hits double digits.
When are we going to hear any news? We just keep going lower and lower.
Flippers. We need real traders here.
False start. In do time like you said we will have a winner here. Gltu
$CLBS wants $3 with this explosion of volume..3-5 month ten bagger mark it.
Pipeline CLBS119 CLBS12 CLBS16 CLBS14
Bouncing off $2.57.
The big breakout on Tuesday was $2.58
Let’s see if we can push back through here.
Clay is a bottom feeder. Give him credit he has a bunch of followers who do the same shorting.
Right after Clay's post. Coincidence?
That would be perfect timing. Battling hard today. Maybe we catch some tail winds. Gltu
$CLBS options expiry tomorrow perfect time for Covid-Lung pr
Very disappointed on my end for sure.
Yes I held some calls expecting a gap up today. Very disappointing...
Let’s hope so. I doubled up today on the sell off.
$CLBS hold it 3-5 months for a ten bagger
Looks like my timing sucked. Lol
Timing is key$
Awe full start. Wow should have waited yesterday. Time to buy some more.
* * $CLBS Video Chart 07-14-2020 * *
Link to Video - click here to watch the technical chart video
Let’s see what AH brings. So far nothing much.
I believe so. Tiny is right. Just need some news for this run to continue. Should be a nice ride.
That was the last Q, Did they do another 2 million after that? maybe like 14 million? Yes still very small...
Followers
|
84
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3108
|
Created
|
03/08/07
|
Type
|
Free
|
Moderators |
Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. We are developing a first- in-class cell therapy product that is based on the notion that our body contains finely tuned mechanisms for self-repair. Our technology leverages and enables these mechanisms in the form of specific cells, using formulations and modes of delivery unique to each medical indication.
The Company’s current product candidates include CLBS119, a CD34+ cell therapy product candidate for the repair of lung damage found in patients with severe COVID-19 infection who experienced respiratory failure, for which the Company plans to initiate a clinical trial in the coming months as well as three developmental treatments for ischemic diseases based on its CD34+ cell therapy platform: CLBS12, recipient of SAKIGAKE designation and eligible for early conditional approval in Japan for the treatment of critical limb ischemia (“CLI”) based on the results of an ongoing clinical trial; CLBS16, the subject of a recently completed positive Phase 2 clinical trial in the U.S. for the treatment of coronary microvascular dysfunction (“CMD”); and CLBS14, a Regenerative Medicine Advanced Therapy (“RMAT”) designated therapy for which the Company has finalized with the U.S. Food and Drug Administration (the “FDA”) a protocol for a Phase 3 confirmatory trial in subjects with no-option refractory disabling angina (“NORDA”).
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |